{"uuid": "08266161-dd41-4c81-9f95-46da0811937d", "tweet_id": "1339714491785883648", "replies": [], "reply_to": null, "avatar": "https://pbs.twimg.com/profile_images/880687855152107521/aXYEx-1E_normal.jpg", "user_handle": "frontline_india", "user_name": "Frontline", "content": "#COVID19 | Clearly a race to the finishing line, with all eyes on the market, is on between all three developers of the #COVIDvaccine \u2014 #PfizerBioNTech, #Moderna-NIAID & #Oxford-AstraZeneca.\n\nBy R. Ramachandran.\n\nhttps://frontline.thehindu.com/the-nation/oxford-vaccine-advantage-covishield-astrazeneca/article33202483.ece\u2026 #replug", "date": "7:30 AM \u00b7 Dec 18, 2020\u00b7TweetDeck", "engagement": "1 Like", "avatar_extension": "jpg"}